ALX Oncology Holdings Stock (NASDAQ:ALXO), Quotes and News Summary

Q: What sector and industry does ALX Oncology Holdings (ALXO) operate in?

ALX Oncology Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ALX Oncology Holdings Stock (NASDAQ: ALXO) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 464.157K
Day Range	- - -
52 Wk Range	3.936 - 17.420
Market Cap	$819.091M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	65
Short Interest	11.07%
Days to Cover	7.21

Recent News

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

Avi Kapoor

United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were lower, with the Dow Jones index falling over 50 points on Wednesday.

Avi Kapoor

ALX Oncology Has 'Elevated Valuation' - Analyst Downgrades Stock, Highlights Need For Development De-Risking Beyond Gastric Cancer

ALX Oncology's evorpacept, poised for pivotal HER2+ gastric cancer development. Caution prevails due to sub-$100 million market size; await additional plans backed by phase 1/2 data.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Alx Oncology Holdings Inc

Sector

Health Care

Industry

Biotechnology

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fi...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ALX Oncology Holdings (ALXO) stock?

You can purchase shares of ALX Oncology Holdings (NASDAQ: ALXO) through any online brokerage.

View our list of the best stock brokerages.

Who are ALX Oncology Holdings's (ALXO) competitors?

Other companies in ALX Oncology Holdings’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL) and Centessa Pharmaceuticals (NASDAQ:CNTA).

What is the target price for ALX Oncology Holdings (ALXO) stock?

The latest price target for ALX Oncology Holdings (NASDAQ: ALXO) was reported by Cantor Fitzgerald on Friday, April 12, 2024. The analyst firm set a price target for 0.00 expecting ALXO to fall to within 12 months (a possible -100.00% downside). 19 analyst firms have reported ratings in the last year.

Current Stock Price for ALX Oncology Holdings (ALXO)?

The stock price for ALX Oncology Holdings (NASDAQ: ALXO) is $16.22 last updated April 24, 2024 at 4:00 PM EDT.

Does ALX Oncology Holdings (ALXO) pay a dividend?

There are no upcoming dividends for ALX Oncology Holdings.

When is ALX Oncology Holdings (NASDAQ:ALXO) reporting earnings?

ALX Oncology Holdings’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is ALX Oncology Holdings (ALXO) going to split?

There is no upcoming split for ALX Oncology Holdings.

What sector and industry does ALX Oncology Holdings (ALXO) operate in?

ALX Oncology Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-